The healthcare industry is booming with innovation, and venture capitalists are taking notice. From digital health to biotech breakthroughs, top investors are fueling the future of care. In this blog, discover the leading VC firms backing the next wave of healthcare startups transforming lives across the globe.
Meet the VC Firms Investing in the Future of Healthcare
The healthcare space is rapidly evolving, and behind every breakthrough is a network of visionary investors. These VC firms aren’t just providing capital — they’re driving innovation, scaling solutions, and shaping the future of patient care. Here are some of the most influential firms investing in healthcare today.
1. New Enterprise Associates
- Investment Stage: Convertible Note, Debt, Early Stage Venture, Late Stage Venture, Post-IPO, Venture
- Number of Companies Invested: 2,232
- Number of Lead Investments: 790 (Vori Health, Waymark, Abcuro, etc)
- Location: Menlo Park, CA
- Founded Year: 1977
- Investor Type: Venture Capital
New Enterprise Associates is a venture capital firm based in Menlo Park, California, that has been supporting startups since 1977. With a strong focus on health care and technology, they help early and late-stage companies grow and succeed. Over the years, they’ve backed more than 2,200 companies, leading investments in many well-known names like Vori Health, Waymark, and Abcuro. Their goal is simple — to partner with bold founders and turn big ideas into real-world solutions.

2. Atlas Venture
- Investment Stage: Early Stage Venture, Late Stage Venture, Post-IPO, Seed, Venture
- Number of Companies Invested: 613
- Number of Lead Investments: 171 (GRO Biosciences, Aiolos Bio, Nimbus Therapeutics, etc)
- Location: Cambridge, MA
- Founded Year: 1980
- Investor Type: Venture Capital
Atlas Venture is a venture capital firm based in Cambridge, Massachusetts, that focuses on building and investing in biotech startups. Since 1980, they’ve been helping turn early ideas into promising healthcare solutions. With over 600 companies backing and leading investments in innovative firms like GRO Biosciences, Aiolos Bio, and Nimbus Therapeutics, Atlas is known for spotting potential early. Their mission is clear — to work with scientists and entrepreneurs to create new medicines that make a real difference in people’s lives.

3. RA Capital Management
- Investment Stage: Convertible Note, Debt, Early Stage Venture, Late Stage Venture, Post-IPO, Private Equity, Seed, Venture
- Number of Companies Invested: 446
- Number of Lead Investments: 149 (Aktis Oncology, Bambusa Therapeutics, Evommune, etc)
- Location: Boston, MA
- Founded Year: 2001
- Investor Type: Private Equity Firm, Venture Capital
RA Capital Management is a Boston-based investment firm that focuses on life sciences and drug development. Since 2001, they’ve been backing healthcare companies at all stages—from seed to post-IPO. With nearly 450 investments and lead roles in startups like Aktis Oncology, Bambusa Therapeutics, and Evommune, they play a big part in bringing new treatments to market. RA Capital works closely with scientists and entrepreneurs to turn research into real solutions that can improve lives.

4. StartUp Health
- Investment Stage: Early Stage Venture, Grant, Seed, Venture
- Number of Companies Invested: 390
- Number of Lead Investments: 9 (SANITAS, hav., etc)
- Location: New York, NY
- Founded Year: 2011
- Investor Type: Venture Capital
StartUp Health is a New York-based venture capital firm that supports bold health care startups around the world. Since 2011, they’ve been on a mission to back a global community of “Health Transformers” working toward big, game-changing goals called health moonshots. With nearly 400 investments and lead roles in companies like SANITAS and hav., StartUp Health focuses on early-stage ideas that aim to make health care better for everyone. Their vision is clear — to help innovators turn their passion into lasting impact.

5. Versant Ventures
- Investment Stage: Early Stage Venture, Late Stage Venture, Post-IPO
- Number of Companies Invested: 382
- Number of Lead Investments: 105 (Helicore Biopharma, Matterhorn Biosciences, Gritstone Bio, etc)
- Location: Menlo Park, CA
- Founded Year: 1999
- Investor Type: Venture Capital
Versant Ventures is a venture capital firm based in Menlo Park, California, that focuses on investing in healthcare companies. Since 1999, they’ve helped bring medical breakthroughs to life by backing early and late-stage startups. With over 380 investments and lead roles in companies like Helicore Biopharma, Matterhorn Biosciences, and Gritstone Bio, Versant is known for supporting bold ideas with strong science behind them. Their mission is to help health care innovators turn big challenges into real solutions that improve lives.

6. SV Health Investors
- Investment Stage: Debt, Early Stage Venture, Late Stage Venture, Post-IPO, Private Equity, Seed, Venture
- Number of Companies Invested: 317
- Number of Lead Investments: 75 (Perfuze, Spineology, Therini Bio, etc)
- Location: Boston, MA
- Founded Year: 1993
- Investor Type: Private Equity Firm, Venture Capital
SV Health Investors is a Boston-based venture capital and private equity firm that focuses on the biotechnology and healthcare space. Since 1993, they’ve been helping grow companies that are working to improve health and save lives. With over 300 investments and lead roles in innovative startups like Perfuze, Spineology, and Therini Bio, SV Health brings both experience and passion to the table. Their goal is to support science-driven teams and turn cutting-edge ideas into real-world health solutions.

7. Innova Memphis
- Investment Stage: Convertible Note, Early Stage Venture, Seed, Venture
- Number of Companies Invested: 313
- Number of Lead Investments: 65 (Isomark Health, MedHaul, Hera Health Solutions, etc)
- Location: Memphis, TN
- Founded Year: 2007
- Investor Type: Venture Capital
Innova Memphis is a venture capital firm based in Memphis, Tennessee, that invests in early-stage startups with big ideas in health care, biosciences, technology, and AgTech. Since 2007, they’ve supported over 300 companies, helping bring new solutions to life. With lead investments in promising firms like Isomark Health, MedHaul, and Hera Health Solutions, Innova focuses on turning early innovation into real impact. Their mission is to back passionate founders who are working to solve important problems and improve lives.

8. Domain Associates
- Investment Stage: Early Stage Venture, Late Stage Venture, Private Equity
- Number of Companies Invested: 305
- Number of Lead Investments: 63 (Seraphina Therapeutics, RightCare Solutions, Sera Prognostics, etc)
- Location: San Diego, CA
- Founded Year: 1985
- Investor Type: Venture Capital
Domain Associates is a San Diego-based venture capital firm that focuses only on life sciences. Since 1985, they’ve been helping healthcare startups grow by investing in early and late-stage companies. With over 300 investments and lead roles in firms like Seraphina Therapeutics, RightCare Solutions, and Sera Prognostics, Domain is known for supporting science that can change lives. Their mission is to work with passionate teams to bring new medical ideas to the world and improve patient care.

9. MPM Capital
- Investment Stage: Early Stage Venture, Late Stage Venture, Private Equity, Seed
- Number of Companies Invested: 300
- Number of Lead Investments: 96 (āshibio, Crossbow Therapeutics, Firefly Bio, etc)
- Location: Boston, MA
- Founded Year: 1996
- Investor Type: Private Equity Firm, Venture Capital
MPM Capital is a Boston-based venture capital and private equity firm that invests in biotech companies focused on fighting cancer. Since 1996, they’ve been helping turn breakthrough science into life-saving treatments. With 300 investments and lead roles in companies like āshibio, Crossbow Therapeutics, and Firefly Bio, MPM Capital is known for backing strong teams with bold ideas. Its mission is to support the development of new therapies that bring real hope to patients and families worldwide.

10. Rev1 Ventures
- Investment Stage: Convertible Note, Early Stage Venture, Grant, Late Stage Venture, Seed, Venture
- Number of Companies Invested: 243
- Number of Lead Investments: 61 (Rhyme, sight4all, Invirsa, etc)
- Location: Columbus, OH
- Founded Year: 2005
- Investor Type: Corporate Venture Capital, Venture Capital
Rev1 Ventures is a venture capital firm and startup studio based in Columbus, Ohio, that helps healthcare and tech startups grow. Since 2005, they’ve combined funding with hands-on support to turn early ideas into strong, scalable businesses. With over 240 investments and lead roles in companies like Rhyme, sight4all, and Invirsa, Rev1 focuses on backing founders with big visions. Their goal is to connect startups with the resources they need to solve real-world problems and drive innovation forward.

11. Vivo Capital
- Investment Stage: Early Stage Venture, Late Stage Venture, Post-IPO, Private Equity, Venture
- Number of Companies Invested: 223
- Number of Lead Investments: 62 (INBRACE, Visirna Therapeutics, Preventice Solutions, etc)
- Location: Palo Alto, CA
- Founded Year: 1996
- Investor Type: Private Equity Firm, Venture Capital
Vivo Capital is a global health care investment firm based in Palo Alto, California. Since 1996, they’ve been supporting companies that are working to improve health and patient care. With around $5.8 billion in assets under management, Vivo invests in both early and late-stage ventures. They’ve backed over 220 companies, leading investments in names like INBRACE, Visirna Therapeutics, and Preventice Solutions. Vivo’s mission is to help health care innovators grow and bring life-changing solutions to people around the world.

12. OUP (Osage University Partners)
- Investment Stage: Early Stage Venture, Late Stage Venture, Post-IPO, Seed, Venture
- Number of Companies Invested: 220
- Number of Lead Investments: 11 (VeraDermics, Cleave Therapeutics, Capella BioScience, etc)
- Location: Bala Cynwyd, PA
- Founded Year: 2009
- Investor Type: University Program, Venture Capital
OUP (Osage University Partners) is a venture capital firm based in Bala Cynwyd, Pennsylvania, that invests in health care startups born from university research. Since 2009, they’ve partnered with leading academic institutions to turn groundbreaking discoveries into real-world treatments. With over 220 investments and lead roles in companies like VeraDermics, Cleave Therapeutics, and Capella BioScience, OUP helps bring science out of the lab and into patients’ lives. Its mission is to support the next wave of healthcare innovation by backing the bright ideas of university researchers.

13. SR One
- Investment Stage: Early Stage Venture, Late Stage Venture, Post-IPO, Private Equity, Seed, Venture
- Number of Companies Invested: 197
- Number of Lead Investments: 60 (Zenas BioPharma, Nimbus Therapeutics, Fore Biotherapeutics, etc)
- Location: Cambridge, MA
- Founded Year: 1985
- Investor Type: Venture Capital
SR One is a venture capital firm based in Cambridge, Massachusetts, and was originally founded as the investment arm of GlaxoSmithKline. Since 1985, they’ve been backing healthcare startups with strong science and big potential. With nearly 200 investments and lead roles in companies like Zenas BioPharma, Nimbus Therapeutics, and Fore Biotherapeutics, SR One focuses on advancing new medicines and therapies. Their goal is to support innovative teams that are working to transform patient care and improve health outcomes worldwide.

14. Maverick Ventures
- Investment Stage: Early Stage Venture, Late Stage Venture, Seed, Venture
- Number of Companies Invested: 196
- Number of Lead Investments: 58 (Zenas BioPharma, Nimbus Therapeutics, Fore Biotherapeutics, etc)
- Location: San Francisco, CA
- Founded Year: 2015
- Investor Type: Venture Capital
Maverick Ventures is a San Francisco-based venture capital firm that invests in early-stage healthcare and tech-driven startups. Founded in 2015 as part of Maverick Capital, the firm supports bold ideas that can make a real impact. With nearly 200 investments and lead roles in companies like Zenas BioPharma, Nimbus Therapeutics, and Fore Biotherapeutics, Maverick Ventures backs founders who are changing the future of health. Its mission is to help build breakthrough businesses that improve lives and solve important challenges.

15. Primary Venture Partners
- Investment Stage: Early Stage Venture, Late Stage Venture, Seed
- Number of Companies Invested: 191
- Number of Lead Investments: 53 (Balanced, Small Door, Stellar Health, etc)
- Location: Manhattan, NY
- Founded Year: 2015
- Investor Type: Venture Capital
Primary Venture Partners is a New York-based venture capital firm that invests in early-stage startups across health care, B2B SaaS, fintech, and more. Since 2015, they’ve focused on helping founders build strong companies from the ground up. With nearly 200 investments and lead roles in health-focused startups like Balanced, Small Door, and Stellar Health, Primary supports bold ideas that aim to improve lives. Their mission is simple — to be hands-on partners in helping startups grow and succeed in meaningful ways.

16. XRC Ventures
- Investment Stage: Convertible Note, Debt, Early Stage Venture, Non-Equity Assistance, Seed, Venture
- Number of Companies Invested: 166
- Number of Lead Investments: 85 (Incora Health, MedsNow, Avi Health, etc)
- Location: New York, NY
- Founded Year: 2015
- Investor Type: Accelerator, Venture Capital
XRC Ventures is a New York-based venture firm and startup accelerator that invests in consumer healthtech, retail tech, and consumer goods. Since 2015, they’ve helped early-stage startups grow by providing both funding and hands-on support. With over 160 investments and lead roles in companies like Incora Health, MedsNow, and Avi Health, XRC backs bold founders with fresh ideas. Their mission is to help build the next wave of health-focused consumer brands that improve everyday lives.

17. Asset Management Ventures (AMV)
- Investment Stage: Convertible Note, Debt, Early Stage Venture, Late Stage Venture, Private Equity, Seed, Venture
- Number of Companies Invested: 157
- Number of Lead Investments: 31 (Endless Health, SubjectWell, HealthTap, etc)
- Location: Palo Alto, CA
- Founded Year: 1965
- Investor Type: Micro VC, Venture Capital
Asset Management Ventures (AMV) is a venture capital firm based in Palo Alto, California, with a long history of supporting innovation since 1965. They focus on early-stage investments in digital health, life sciences, and tech. With over 150 investments and lead roles in companies like Endless Health, SubjectWell, and HealthTap, AMV backs startups working to improve how we manage and experience health. Their goal is to help visionary founders turn smart ideas into real-world solutions that make life better.

18. CincyTech
- Investment Stage: Early Stage Venture, Late Stage Venture, Seed, Venture
- Number of Companies Invested: 147
- Number of Lead Investments: 77 (IncludeHealth, Kurome Therapeutics, Invirsa, etc)
- Location: Cincinnati, OH
- Founded Year: 2006
- Investor Type: Venture Capital
CincyTech is a Cincinnati-based venture capital firm that invests in health care and tech startups across Ohio. Since 2006, they’ve been one of the Midwest’s most active seed funds, backing early and growth-stage companies with big ideas. With nearly 150 investments and lead roles in startups like IncludeHealth, Kurome Therapeutics, and Invirsa, CincyTech helps turn local innovation into lasting impact. Their mission is to support entrepreneurs who are building the future of health and technology in the heart of the U.S.

19. Third Rock Ventures
- Investment Stage: Early Stage Venture, Late Stage Venture, Post-IPO, Seed
- Number of Companies Invested: 143
- Number of Lead Investments: 65 (ARTBIO, Editas Medicine, Agios Pharmaceuticals, etc)
- Location: Boston, MA
- Founded Year: 2007
- Investor Type: Venture Capital
Third Rock Ventures is a Boston-based venture capital firm that builds and invests in life science companies with the power to change lives. Since 2007, they’ve focused on early and growth-stage startups that bring bold ideas to health care. With lead investments in companies like ARTBIO, Editas Medicine, and Agios Pharmaceuticals, Third Rock helps turn cutting-edge science into real treatments. Their mission is to support visionary teams creating breakthroughs that lead to better health for everyone.

20. Boston Millennia Partners
- Investment Stage: Early Stage Venture, Late Stage Venture, Private Equity, Seed, Venture
- Number of Companies Invested: 141
- Number of Lead Investments: 25 (Predix Pharmaceuticals, CombinatoRx, CardioMEMS, etc)
- Location: Boston, MA
- Founded Year: 1984
- Investor Type: Private Equity Firm, Venture Capital
Boston Millennia Partners is a venture capital and private equity firm based in Boston, Massachusetts, that invests in fast-growing health care and business services companies. Since 1984, they’ve supported startups with strong ideas and big potential. With over 140 investments and lead roles in companies like Predix Pharmaceuticals, CombinatoRx, and CardioMEMS, they focus on helping teams bring new medical solutions to market. Their mission is to back innovation that drives better health outcomes and long-term success.

Conclusion
As healthcare continues to transform, these VC firms play a critical role in bringing groundbreaking solutions to life. Whether you’re a founder, researcher, or curious observer, keeping an eye on these investors offers a glimpse into where the industry is headed. The future of healthcare is being funded now.
FAQs
Q. Why do VC firms invest in healthcare?
Answer: VC firms invest in healthcare due to its massive growth potential, innovation-driven nature, and the increasing global demand for advanced medical solutions and technologies.
Q. How do I find the right VC firm for my healthcare startup?
Answer: Research firms with a track record in healthcare investments, align your startup’s vision with their portfolio focus, and look for those active in your specific niche (e.g., biotech, digital health, AI in healthcare).
Q. What stages do VC firms typically invest in?
Answer: Healthcare VC firms invest across all stages—from seed and early-stage funding to late-stage and even IPO rounds—depending on the firm’s investment strategy.